China Infrastructure Construction Corp (OTCMKTS:CHNC) Stock On Radar: Here is Why

Yesterday China Infrastructure Construction Corp (OTCMKTS:CHNC) came into the news cycle after it announced that it had successfully completed the ‘research and discovery’ stage of its strategic framework related to the development of future clinical trials to test the effectiveness of CBD in cancer treatment.

Trading Data

On Monday, CHNC stock ended flat at $0.0006 with more than 713.23K shares, compared to its average volume of 2.64 million shares. The stock moved within a range of $0.0005 – 0.0006 after opening trade at $0.0006.

CBIH Announces the Completion of the “Phase of Research and Discovery” for Its Phytotherapy Cancer Scientific Project

In the phase that had been completed by the company, its scientific team had managed to develop molecular biology data analysis for the exploration of biomarkers and targets in a complex disease with more than 200 subtypes. Following the completion of this particular stage, the scientists’ group at China Infrastructure Construction Corp developed a number of formulation proposals meant for different stages of cancer.

The National Medical Director at China Infrastructure Construction Corp, Dr. Jose Torres, spoke the situation too. He noted that as per estimates by the American Cancer Society there were going to be 609,820 cancer related deaths and 1,958,310 new cancer cases in 2023 alone. He went on state that those were alarming estimates and should serve as a trigger for the call to action to make cancer control measures a priority. He added that it was also the time to reduce the burden of cancer on individuals and society.